海通國際(00665.HK)大股東提私有化計劃獲法院批准
海通國際(00665.HK)公布,有關獲大股東海通證券(06837.HK)提私有化,法院於百慕達時間上周五(5日)批准該計劃。法院批准該計劃的命令副本預期將於明日(9日)或之前送交百慕達公司註冊處處長以供登記,屆時條件將獲悉數達成。
假設所有未完成條件獲達成或豁免,預計私有化計劃將於明日生效,預期撤銷公司股份於聯交所的上市地位生效日期為周四(11日)。倘該計劃並未於3月31日(即最終截止日期)或之前生效,則該計劃將告失效。
公司股份的每手買賣單位將由1,000股股份更改為80萬股股份,自今日(8日)起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.